1.. Introduction {#sec1}
================

UDP-*N*-acetylglucosamine (UDP-GlcNAc) is a UDP sugar and is synthesized from fructose-6-phosphate supplied by the glycolytic pathway (Watzele & Tanner, 1989[@bb18]; Mio *et al.*, 1999[@bb10]; Hofmann *et al.*, 1994[@bb3]; Mio *et al.*, 1998[@bb9]). UDP-GlcNAc is used as a precusor in the synthesis of cell-wall chitin and glycoproteins. Although UDP-GlcNAc is also utilized in mammalian cells, fungi require a larger amount of UDP-GlcNAc owing to the synthesis of the cell wall.

*N*-Acetylglucosamine-phosphate mutase (AGM1; EC 5.4.2.3) is an essential enzyme in the synthesis of UDP-GlcNAc. AGM1 catalyzes the intramolecular transfer of a phosphoryl group. This synthetic step consists of the interconversion of *N*-acetylglucosamine-6-phosphate (GlcNAc-6-P) and *N*-acetylglucosamine-1-phosphate (GlcNAc-1-P). The process of UDP-GlcNAc biosynthesis differs in prokaryotes and eukaryotes and AGM1 has only been identified in eukaryotes (Mio *et al.*, 2000[@bb11]). It is well known that AGM1 requires Mg^2+^ ions to exhibit maximum activity; complete inhibition has also been achieved with Zn^2+^ ions (Cheng & Carlson, 1979[@bb1]; Fernandez-Sorensen & Carlson, 1971[@bb2]). AGM1 is a member of the α-[d]{.smallcaps}-phosphohexomutase superfamily, as it catalyzes a reversible intramolecular phosphoryl transfer on its sugar substrate (Shackelford *et al.*, 2004[@bb17]; Whitehouse *et al.*, 1998[@bb19]). Other superfamily members exist as various oligomeric states (monomers, dimers and trimers) in solution (Jolly *et al.*, 1999[@bb4]; Maino & Young, 1974[@bb7]). Phosphomannomutase/phosphoglucomutase from *Pseudomonas aeruginosa* (PaPMM/PGM; PDB code [1k2y](http://www.rcsb.org/pdb/explore.do?structureId=1k2y)), which catalyzes the reversible conversion of mannose-6-phosphate to mannose-1-phosphate and glucose-6-phosphate to glucose-1-­phosphate, shares 20.7% sequence identity with AGM1 from *Candida albicans* (CaAGM1) as calculated by the program *FASTA* (Lipman & Pearson, 1985[@bb5]; Pearson & Lipman, 1988[@bb13]) and exists as a monomer in solution (Regni *et al.*, 2002[@bb15], 2004[@bb14]). Several structures of enzymes in this superfamily have been reported to date. They are similar to each other, being composed of four domains arranged in a 'heart shape' (Liu, 1997[@bb6]; Regni *et al.*, 2002[@bb15], 2004[@bb14]). However, for AGM1 only the atomic coordinates of the C-terminal domain from *Mus musculus* (112 amino-acid residues of 542 amino-acid residues) has been deposited (PDB code [1wjw](http://www.rcsb.org/pdb/explore.do?structureId=1wjw)) and overall structures have not been determined. Multiple sequence alignment in the superfamily shows that AGM1 has significant sequence similarity to other members with regard to the presumed active-site loops, but that AGM1 has a different relative location of several loops; these loops were not identified as affecting the activity by previous mutation analysis (Shackelford *et al.*, 2004[@bb17]; Mio *et al.*, 2000[@bb11]). Also, little is known about the substrate specificity. Determination of the three-dimensional structure of this enzyme is thus necessary in order to gain a better understanding not only of its catalytic mechanism, but also of the additional important differences betweeen the enzymes included in this superfamily.

Here, we describe the purification, crystallization and preliminary X-ray data for CaAGM1. *C. albicans* is a disease-causing fungus that leads to a life-threatening systemic infection (referred to as 'candidasis') in immunocompromized hosts (Rogers & Balish, 1980[@bb16]). It is impossible for fungi to live without biosynthesis of the cell wall and the chitin of the cell wall is synthesized from UDP-GlcNAc. A specific inhibitor of AGM1 from pathogenic fungi could therefore be a new candidate antifungal reagent that would inhibit cell-wall synthesis.

2.. Purification {#sec2}
================

CaAGM1 is composed of 544 amino-acid residues and its molecular weight is about 60 kDa. For the crystallization experiments, the ORF of CaAGM1 was cloned between the *Bam*HI and *Eco*RI sites of pGEX-2T to express CaAGM1 as a glutathione *S*-transferase (GST) fusion. CaAGM1 was overproduced and sonicated by previously described methods (Mio *et al.*, 2000[@bb11]), except that after the addition of isopropyl 1-thio-galactopyranoside the cells were grown for an additional 22 h at 295 K. The soluble fraction was applied onto a Glutathione Sepharose 4 FastFlow column (Amersham Biosciences, Piscataway, NJ, USA) and was washed with PBS at 277 K. The purified protein was eluted with a GST elution buffer (20 m*M* Tris--HCl, 0.15 *M* NaCl, 10 m*M* glutathione pH 8.5). The GST was then removed by a 16 h treatment with thrombin at 277 K. Finally, this solution was applied onto a DEAE-Toyopearl 650 column (Tosoh, Tokyo, Japan) and eluted using a gradient of 0--0.5 *M* NaCl contained in elution buffer \[20 m*M* Tris--HCl, 1 m*M* EDTA, 5%(*v*/*v*) glycerol pH 7.5\] at 277 K. The purity of the fraction used for crystallization was tested by SDS--PAGE. Gel-filtration chromatography analysis (data not shown) suggested that the purified protein exists as a monomer in solution. The final yield of CaAGM1 per litre of culture is approximately 2.5 mg. It was desalted and concentrated to a volume of 10 mg ml^−1^.

3.. Crystallization {#sec3}
===================

Crystallization attempts were carried out using Crystal Screens 1 and 2, Crystal Screen Cryo and PEG/Ion Screen (Hampton Research, Aliso Viejo, CA, USA). All attempts at crystallization were performed using the sitting-drop vapour-diffusion method at 293 K. Mixtures of 1.25 µl protein solution (10 mg ml^−1^ in 50 m*M* Tris--HCl pH 7.6 and 1 m*M* dithiothreitol) and an equal volume of the reservoir solution were equilibrated against 100 µl reservoir solution. Crystals were obtained using reservoir solution containing 200 m*M* NH~4~H~2~PO~4~ and 14--20%(*w*/*v*) polyethylene glycol 3350 within a week with approximate dimensions of 0.5 × 0.2 × 0.03 mm (Fig. 1[▶](#fig1){ref-type="fig"}).

4.. X-ray data collection {#sec4}
=========================

The crystals were soaked briefly in a cryoprotectant solution prepared by the addition of 15%(*v*/*v*) glycerol to the reservoir solution and the crystals were mounted in a loop and flash-cooled in an N~2~ gas stream at 95 K. X-ray diffraction studies were performed at SPring-8 (BL44B2) and the Photon Factory (BL5). The diffraction data used for the refinement were collected at BL44B2 with a MAR CCD detector using an oscillation angle of 0.5°, 15 s exposure per frame and a wavelength of 1.000 Å. The crystal-to-detector distance was set at 115 mm. Diffraction was observed to a resolution exceeding 1.8 Å. The data set from a single crystal was processed and scaled using the programs *DENZO* and *SCALEPACK* from the *HKL*2000 package (Otwinowski & Minor, 1997[@bb12]).

The crystals were found to belong to the primitive monoclinic system and systematic absences of reflections (*k* = 2*n* + 1 at 0*k*0) indicated the space group of the data set to be *P*2~1~. The statistics for the intensity data are shown in Table 1[▶](#table1){ref-type="table"}. Assuming the presence of two CaAGM1 molecules per asymmetric unit, the calculated Matthews coefficient *V* ~M~ was 2.42 Å^3^ Da^−1^ (Matthews, 1968[@bb8]), which corresponds to a solvent content of 49.2%. Phasing by the multiple isomorphous replacement method and the structure refinement were successful and the structure will be published soon.
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###### Data-collection statistics for CaAGM1

Values for the highest resolution shell are in parentheses.

  ----------------------------------------------- ----------------------------------------------------
  Space group                                     *P*2~1~
  Unit-cell parameters (Å, °)                     *a* = 60.17, *b* = 130.22, *c* = 77.96, β = 106.68
  No. of measured reflections                     328097
  No. of independent reflections                  81775
  Resolution range (Å)                            50--1.93 (2.00--1.93)
  *R*~merge~[†](#tfn1){ref-type="table-fn"} (%)   4.1 (25.4)
  Completeness (*I* \> 1σ) (%)                    94.9 (85.0)
  *I*/σ(*I*)                                      31.3 (4.8)
  ----------------------------------------------- ----------------------------------------------------

*R* ~merge~ = , where *I* ~*i*~ is the observed intensity and 〈*I* ~*i*~〉 is the average intensity over symmetry-equivalent measurements.
